Corvus Pharmaceuticals, Inc.

BRIDGEWAY CAPITAL MANAGEMENT, LLC CRVS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

26,700

Value ($000)

206

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	206	0.0%	26,700	12/31/2025
2025 Q3	11/14/2025	492	0.0%	66,700	9/30/2025
2025 Q2	8/14/2025	267	0.0%	66,700	6/30/2025
2025 Q1	5/15/2025	131	0.0%	41,300	3/31/2025
2024 Q4	2/14/2025	221	0.0%	41,300	12/31/2024
2024 Q3	11/14/2024	672	0.0%	127,300	9/30/2024
2024 Q2	8/14/2024	232	0.0%	127,300	6/30/2024
2024 Q1	5/15/2024	399	0.0%	224,300	3/31/2024
2023 Q4	2/14/2024	263	0.0%	149,300	12/31/2023
2023 Q3	11/14/2023	218	0.0%	149,300	9/30/2023
2023 Q2	8/14/2023	250	0.0%	109,300	6/30/2023
2023 Q1	5/15/2023	145	0.0%	159,300	3/31/2023
2022 Q4	2/14/2023	135	0.0%	159,300	12/31/2022
2022 Q3	11/14/2022	130	0.0%	159,300	9/30/2022
2022 Q2	8/15/2022	158	0.0%	159,300	6/30/2022
2022 Q1	5/16/2022	261	0.0%	159,300	3/31/2022
2021 Q4	2/14/2022	541	0.0%	224,300	12/31/2021
2021 Q3	11/15/2021	771	0.0%	159,300	9/30/2021
2021 Q2	8/16/2021	559	0.0%	209,300	6/30/2021
2021 Q1	5/17/2021	629	0.0%	204,300	3/31/2021
2020 Q4	2/16/2021	476	0.0%	133,700	12/31/2020
2020 Q3	11/16/2020	536	0.0%	133,700	9/30/2020
2020 Q2	8/31/2020	364	0.0%	133,700	6/30/2020
2020 Q1	5/15/2020	282	0.0%	133,700	3/31/2020
2019 Q4	2/14/2020	727	0.0%	133,700	12/31/2019